Advertisement

Topics

Physicochemical and biological characterization study of copy biological tocilizumab

05:08 EST 10 Nov 2017 | Generics and Biosimilars Initiative

Researchers in China have developed a copy biological of F. Hoffmann-La Roche’s  (Roche) arthritis treatment Actemra (tocilizumab). A recent study compares it to the originator, finding it to be highly similar in terms of its physical, chemical and biological characteristics [1].

Original Article: Physicochemical and biological characterization study of copy biological tocilizumab

NEXT ARTICLE

More From BioPortfolio on "Physicochemical and biological characterization study of copy biological tocilizumab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...